Jayne Galinsky is an economics and outcomes researcher, working on an NIHR-funded, mixed-methods, evaluation of community wealth building on economic and health outcomes in Scotland.
Jayne holds a PhD in Health Sciences from the University of Stirling and previously worked as a research economist at RTI-Health Solutions, working on patient preference studies for use in HTA and regulatory decision making.
Prior to this, Jayne was head of research at Myeloma UK and Myeloma Patients Europe, where she worked on preference studies generating evidence for HTA in the UK and Europe. She has been part of international consortium projects such as IMI-PREFER and SISAQOL-IMI, generating guidance on how to use patient preference data in medical product decision making, and how to analyse PRO data in cancer clinical trials.
Jayne has experience of working on mixed methods research projects across the academic, private, and public sectors and has interests in health economics and decision making in Scotland.